|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4748 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61P 25/26 | (2006.01) |
| (11) | Number of the document | 2506712 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10834900.2 |
| Date of filing the European patent application | 2010-10-13 | |
| (97) | Date of publication of the European application | 2012-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-27 |
| (46) | Date of publication of the claims translation | 2019-06-25 |
| (86) | Number | PCT/US2010/052437 |
| Date | 2010-10-13 |
| (87) | Number | WO 2011/068594 |
| Date | 2011-06-09 |
| (30) | Number | Date | Country code |
| 266881 P | 2009-12-04 | US |
| (72) |
SILVERMAN, Bernard, US
FU, Fen-Ni, US
GUO, Chengyun, US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Morfinano dariniai, skirti narkotinių medžiagų perdozavimo gydymui |
| MORPHINAN DERIVATIVES FOR THE TREATMENT OF DRUG OVERDOSE |
| Payment date | Validity (years) | Amount | |
| 2024-09-18 | 15 | 289.00 EUR |
| 2025-10-13 |